Targeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promise

Targeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promiseTargeted therapies: Precision medicine for ATC — BRAF and MEK inhibition shows promise, Published online: 17 November 2017; doi:10.1038/nrclinonc.2017.181

Source: Nature Clinical Practice Oncology - November 17, 2017 Category: Cancer & Oncology Authors: David Killock Source Type: research